Current status of research on osteoporosis in COPD: a systematic review von Graat-Verboom, L, Wouters, E. F. M, Smeenk, F. W. J. M, van den Borne, B. E. E. M, Lunde, R, Spruit, M. A

Volltext

Segmental spinal anaesthesia for cholecystectomy in a patient with severe lung disease von van Zundert, A.A.J., Stultiens, G, Jakimowicz, J.J., van den Borne, B.E.E.M., van der Ham, W.G.J.M., Wildsmith, J.A.W.

Volltext

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer von van der Wekken, A J, Pelgrim, R, 't Hart, N, Werner, N, Mastik, M F, Hendriks, L, van der Heijden, E H F M, Looijen-Salamon, M, de Langen, A J, Staal-van den Brekel, J, Riemersma, S, van den Borne, B E, Speel, E J M, Dingemans, A-M C, Hiltermann, T J N, van den Berg, A, Timens, W, Schuuring, E, Groen, H J M

Volltext

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands von Cramer-van der Welle, Christine M., Verschueren, Marjon V., Tonn, Merel, Peters, Bas J. M., Schramel, Franz M. N. H., Klungel, Olaf H., Groen, Harry J. M., van de Garde, Ewoudt M. W.

Volltext

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVAL... von Dingemans, A.-M. C., Groen, H.J.M., Herder, G.J.M., Stigt, J.A., Smit, E.F., Bahce, I., Burgers, J.A., van den Borne, B.E.E.M., Biesma, B., Vincent, A., van der Noort, V., Aerts, J.G.

Volltext

Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands von Janssen-Heijnen, M.L.G, Lemmens, V.E.P.P, van den Borne, B.E.E.M, Biesma, B, Oei, S.B, Coebergh, J.W.W

Volltext

A pulmonary shadow after lobectomy: an unexpected diagnosis von CRIJNS, K, JANSEN, F. H, VAN STRATEN, A. H. M, VAN DEN BORNE, B. E. E. M

Volltext

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity von Landewe, Robert BM, van den Borne, Ben EEM, Breedveld, Ferdinand C, Dijkmans, Ben AC

Volltext

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study von de Joode, Karlijn, Dumoulin, Daphne W., Tol, Jolien, Westgeest, Hans M., Beerepoot, Laurens V., van den Berkmortel, Franchette W.P.J., Mutsaers, Pim G.N.J., van Diemen, Nico G.J., Visser, Otto J., Oomen-de Hoop, Esther, Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., Hendriks, Lizza E.L., Haanen, John B.A.G., de Vries, Elisabeth G.E., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., van Loenhout, C.J., van der Leest, C.H., Becker-Commissaris, A., Borgers, J.S.W., Terhegggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Klaver, Y., Hamberg, A.P., Libourel, E.J., Strobbe, L., Cloos, M., Geraedts, E.J., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Nuij, V.J.A.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., Westeinde, S.C. van 't, Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., Herder, G.J.M., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Herbschleb, K.H., Kastelijn, E.A., Brocken, P., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., Peerdeman, A.L., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H., Bootsma, G.P.

Volltext

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer von Cramer-van der Welle, Christine M, Peters, Bas J M, Schramel, Franz M N H, Klungel, Olaf H, Groen, Harry J M, van de Garde, Ewoudt M W

Volltext

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium von de Joode, Karlijn, Tol, Jolien, Hamberg, Paul, Cloos, Marissa, Kastelijn, Elisabeth A., Borgers, Jessica S.W., Nuij, Veerle J.A.A., Klaver, Yarne, Herder, Gerarda J.M., Mutsaers, Pim G.N.J., Dumoulin, Daphne W., Oomen-de Hoop, Esther, van Diemen, Nico G.J., Libourel, Eduard J., Geraedts, Erica J., Bootsma, Gerben P., van der Leest, Cor H., Peerdeman, Anne L., Herbschleb, Karin H., Visser, Otto J., Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., de Vries, Elisabeth G.E., Hendriks, Lizza E.L., Beerepoot, Laurens V., Westgeest, Hans M., van den Berkmortel, Franchette W.P.J., Haanen, John B.A.G., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., Becker-Commissaris, A., Terheggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Strobbe, L., Koekkoek, J.A.F., Brocken, P., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., van 't Westeinde, S.C., Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H.

Volltext

Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer von Cramer‐van der Welle, Christine M., Schramel, Franz M. N. H., Leeuwen, Arvid S., Groen, Harry J. M., Garde, Ewoudt M. W., Borne, B.E.E.M., Putten, J.W.G., Schouwink, J.H., Smit, A.A.J., Vermeer, L.C.

Volltext

Cyclosporin A therapy in rheumatoid arthritis : only strict application of the guidelines for safe use can prevent irreversible renal function loss von VAN DEN BORNE, B. E. E. M, LANDEWE, R. B. M, GOEI THE, H. S, BREEDVELD, F. C, DIJKMANS, B. A. C

Volltext

The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer von Kicken, M.P., Kilinc, H.D., Cramer-van der Welle, C.M., Houterman, S., van den Borne, B.E.E.M., Smit, A.A.J., van de Garde, E.M.W., Deenen, M.J.

Volltext

Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline von van den Borne, B E, Landewé, R B, Rietveld, J H, Goei The, H S, Griep, E N, Breedveld, F C, Dijkmans, B A

Volltext

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis von Borne, BE, Landewe, RB, Goei The, HS, Mattie, H, Breedveld, FC, Dijkmans, BA

Volltext

Low Dose Cyclosporine in Early Rheumatoid Arthritis: Effective and Safe after Two Years of Therapy when Compared with Chloroquine von Borne, B. E. E. M. van den, Landewé, R. B. M., Goei The, H. S., Breedveld, F. C., Dijkmans, B. A. C.

Volltext

No increased risk of malignancies and mortality in cyclosporin A‐treated patients with rheumatoid arthritis von van den Borne, B. E. E. M., Landewé, R. B. M., Houkes, I., Schild, F., van der Heyden, P. C. W., Hazes, J. M. W., Vandenbroucke, J. P., Zwinderman, A. H., Goei The, H. S., Breedveld, F. C., Bernelot Moens, H. J., Kluin, P. M., Dijkmans, B. A. C.

Volltext

A randomized placebo-controlled phase III study of docetaxel/carboplatin with celecoxib in patients (pts) with advanced non-small cell lung cancer (NSCLC): The NVALT-4 study von Groen, H., Hochstenbag, M. M., van Putten, J. W., Vincent, A., Dalesio, O., Biesma, B., Smit, H. J., Termeer, A., van den Borne, B. E., Schramel, F. M.

Volltext

A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC) von Maas, K. W., Sharouni, S. Y., Phernambucq, E. C., Stigt, J. A., Groen, H. J., van den Borne, B. E., Senan, S., Paul, R. M., Smit, E. F., Schramel, F. M.

Volltext